Blood based proteomic classifier for molecular characterization of pulmonary nodules.

Learning Objectives:

1. Utilize the mathematics to understand and improve the expansion of a Lung Cancer Screening program.
2. Introduce the concept and significance of blood-base proteomic classifiers for molecular characterization of pulmonary nodules.
3. Present the validation and clinical utility of the blood-based proteomic classifier in accurately distinguishing between benign and malignant pulmonary nodules.
4. Discuss the potential impact of the blood-based proteomic classifier on clinical decision-making, patient management, and overall outcomes in the field of pulmonary nodule evaluation.